Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 

Background

​Gwilym Attwell is a Principal in Fish & Richardson’s Delaware* office, managing the local presence of Fish’s highly regarded patent prosecution and counseling practice. His practice emphasizes U. S. and foreign patent prosecution, opinion work, due diligence studies, and client counseling in the fields of biotechnology, medical devices, and pharmaceuticals. He has counseled clients on biotech, biomedical, chemical, and pharmaceutical patent applications involving, for example, vaccines, antibodies, genomics, polypeptides, small molecule inhibitors, gene therapy, diagnostics, and therapeutics. He often assists clients in the strategic development and monetization of internal patent portfolios, patent process implementation and the assessment of third-party IP collaborations.

Mr. Attwell’s technical experience includes having served as a pharmacologist at Wyeth-Ayerst Research in the Bone Metabolism and Osteoporosis Research department, where he developed and implemented high-throughput screening assays to identify lead compounds and performed basic research using cell and molecular biology. He was also a research technician at the Cleveland Clinic Research Institute, where he performed research on pathogenic viruses, e.g., vesicular stomatitis virus and human parainfluenza viruses.

*Not admitted to practice in Delaware – practice in Delaware limited to federal courts and agencies listed below or otherwise authorized by law.

Education

J.D., Temple University Beasley School of Law 1997


M.S., Miami University, Oxford, Ohio 1992
Zoology


B.S., Purdue University 1989
Neurobiology and Animal Physiology

Admissions

  • U.S. Patent and Trademark Office 2000
  • Pennsylvania 1997
  • New Jersey
  • District of Columbia 2011
  • U.S. District Court for the Eastern District of Pennsylvania

Memberships & Affiliations

​Member: BIO Pennsylvania BIO Delaware BIO Philadelphia Intellectual Property Association.
Mr. Attwell has participated as an invited speaker at BIO-Europe (2007); Biotech PA NJ DE (2006, 2007; 2008; 2009); Temple University School of Law (2008); the University of Pennsylvania (2006, 2007, 2008), and the University of Maryland (2008). Mr. Attwell is on the programming committees for BIO2009, Pennsylvania BIO, and Delaware BIO.

Other Distinctions

Named an "IP Star" by Managing Intellectual Property (2013-2016).​

Named intellectual property "Life Sciences Star" by LMG Life Sciences (2012-2013, 2015-2016).

Recognized in "The World’s Leading Patent Practitioners" by IAM Patent 1000 (2012-2016).

Ranked in Chambers USA (2013, 2014).

Named a "Top Patent Prosecutor" by Patent Research Review/Patent Buddy (2011)​.

Speaking Engagements

“Old Dog, New Tricks: Forward-Thinking Trends for the AIA,” Consero 2015 Global IP Management Forum (June 8, 2015).

"The Eternal Balancing Act: Protecting Your Global IP And Sticking To Budget," Consero 2013 IP Pharma Summit (December 8-10, 2013).

"Maximizing IP Due Diligence to Minimize Risk,’ Consero 2013 Intellectual Property Management Forum (June 24, 2013).

"First Inventor to File Under AIA," Minneapolis Patents on Tap Series (March 7, 2013).

"America Invents Act: Adapting to the New Rules," co-presenter with Steven Carlson, Silicon Valley Life Sciences Series (March 6, 2013).

"America Invents Act: Get Ready for the New Rules," co-presenter with Teresa Lavoie and Todd Garcia, Boston Biotech Series (February 13, 2013).

Recent publications
Quoted in “Mergers, metrics and the AIA,” Intellectual Property Magazine, March 5, 2015

"The Myriad Appeal: Federal Circuit rules that isolated DNA sequences are patent eligible subject matter under § 101" with Cherylyn Mizzo, Lexology, August 2011

"Description proscription? Ariad v. Lilly decision to be reviewed by full court," with Lauren Murphy Pringle and Michael Rosen, Industrial Biotechnology, Fall 2009.

"The Bright Side of Nuclear Winter: Opportunities in the New, New Economy," with Gene Barton, xconomy.com, January 6, 2009.

"Maximizing IP value in an economic downturn (& beyond) in the life science industry," with J. Peter Fasse, Jaclyn M. Mason, and Sean M. Daley, Industrial Biotechnology, Spring 2009.

What's trending with Gwilym

Filter by
News
November 21, 2016
Fish & Richardson Announces Six Principals Named 2016 “Life Science Stars” by LMG Life Sciences
Press Releases
News
June 15, 2016
Fish & Richardson Named to IAM Patent 1000 for National Patent Litigation and Prosecution Practices
Press Releases
News
June 2, 2016
Fish & Richardson Announces 37 Attorneys Named “IP Stars” by Managing Intellectual Property Magazine
Press Releases
News
November 10, 2015
Fish & Richardson Announces Five Principals Named 2015 "Life Sciences Stars" by LMG Life Sciences
Press Releases
News
July 1, 2015
Fish & Richardson Named to IAM Patent 1000 for National Patent Prosecution and Litigation Practices
Press Release
News
July 8, 2014
Fish Announces 39 Attorneys Named “IP Stars” by Managing Intellectual Property Magazine
Press Releases
News
July 1, 2014
Fish & Richardson Named to IAM Patent 1000
Press Releases
News
June 11, 2014
Fish Receives Top “Band 1” National Rankings for Intellectual Property and ITC Practices from Chambers USA 2014
Press Releases
News
February 7, 2014
Fish & Richardson Announces 17 Attorneys Selected for 2014 Chambers USA
Articles
News
September 23, 2013
Fish Announces Six Principals Named 2013 “Life Sciences IP Stars” by LMG Life Sciences
Press Releases
News
June 13, 2013
Fish Named to IAM Patent 1000 for National Patent Prosecution and Litigation Practices
Media Coverage
Articles
News
June 11, 2013
Fish & Richardson Receives Top 2013 “Band 1” Rankings from Chambers USA in Intellectual Property and International Trade
Press Releases
load more topics